A method for preparing diphenhydramine citrate
The method of reacting diphenylbromomethane with dimethylaminoethanol in an organic solvent and then crystallizing it with citric acid solves the problems of high safety risks and high costs in the preparation of diphenhydramine citrate in the prior art, and realizes efficient, safe and low-cost production, which is suitable for industrial application.
Patent Information
- Application Number
- CN202510628128.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-15
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies for preparing diphenhydramine citrate suffer from high safety risks, high costs, stringent equipment requirements, and difficulties in scale-up production, making it difficult to achieve efficient, safe, and quality-controllable production.
The method involves reacting diphenylbromomethane with dimethylaminoethanol in an organic solvent, followed by crystallization with citric acid in an alcohol solvent. This process includes a one-step reaction and a single recrystallization. The synthesis is carried out using an inorganic strong base such as sodium hydroxide, and the reaction conditions are optimized by controlling the temperature and solvent ratio.
This study presents a method for preparing diphenhydramine citrate that is safe, easy to operate, requires minimal equipment, has a short production cycle, low cost, high yield, and high purity, making it suitable for industrial production.
Smart Images

Figure CN123106450A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of drug synthesis technology, and specifically relates to a method for preparing diphenhydramine citrate. Background Technology
[0002] Diphenhydramine citrate, also known as diphenhydramine citrate, has the chemical name N,N-dimethyl-2-(diphenylmethoxy)ethylamine citrate and the chemical formula C. 23 H 29 NO8, diphenhydramine citrate, possesses antihistamine, sedative, local anesthetic, antiemetic, and anti-M-cholinergic effects. Clinically, it is commonly used for skin and mucous membrane allergies, acute allergic reactions, prevention and treatment of motion sickness, hypnosis and preoperative medication, dental local anesthesia, and antitussive effects. It can also be used to treat Parkinson's disease and extrapyramidal symptoms in combination with other drugs. Compared to diphenhydramine hydrochloride, diphenhydramine citrate has enhanced stability, reduced bitterness, decreased irritation, increased lipid solubility, and is more easily absorbed.
[0003]
[0004] As can be seen from the above formula, the structural difference between diphenhydramine citrate and diphenhydramine hydrochloride is that they have different acid radicals. In the preparation of both, the diphenhydramine base is synthesized first, and then the corresponding salt is prepared. Therefore, the key to the preparation is the preparation of diphenhydramine.
[0005] According to the literature review, diphenhydramine mainly has the following five routes, which are described below:
[0006] Route 1: References: Chemical Science; vol.4; nb.7; (2013); p.2822–2827; Science; vol.363; nb.6423; (2019)
[0007]
[0008] Route evaluation: Diphenylchloromethane or diphenylbromomethane is used as a raw material and alkylated with N,N-dimethylethanolamine to obtain diphenhydramine. Because the hydroxyl group in N,N-dimethylethanolamine has low activity, the reaction needs to be carried out at high temperature (120-150℃). The byproducts of the reaction are quaternary ammonium salt and diphenylmethanol.
[0009] Route 2: References: Collection of Czechoslovak Chemical Communications; vol. 49; nb. 11; (1984); p. 2649–2660
[0010]
[0011] Route evaluation: Diphenylmethanol is used as a raw material and alkylated with 2-chloroethyldimethylamine to obtain diphenhydramine. Because 2-chloroethyldimethylamine has low activity, the reaction requires the use of strong base sodium hydride. Sodium hydride is a hazardous material. When scaled up in the workshop, the safety risks are very high, with a high risk of fire and explosion. The requirements for the workshop and environment are quite stringent.
[0012] In addition, 2-chloroethyldimethylamine is basically not available commercially and needs to be made in-house. This small molecule compound, which has no ultraviolet absorption and a low boiling point, is difficult to manufacture in conventional equipment.
[0013] Route 3: Reference: CN103265439B (Qidong Dongyue Pharmaceutical Co., Ltd.)
[0014]
[0015] Route Evaluation: This patent uses diphenylmethanol as a starting material, first preparing intermediate diphenylmethane ether under the catalysis of a sulfonic acid catalyst, and then reacting it with N,N-dimethylethanolamine via an ether exchange reaction to produce diphenhydramine. This type of synthetic method has not been reported in other journal articles or foreign patents, especially the ether exchange reaction, which has very poor feasibility. Furthermore, this process uses a large amount of sulfonic acid catalyst, resulting in high reaction costs.
[0016] Route 4: Reference: CN104892435B (Jiaxing University)
[0017]
[0018] Route Evaluation: This patent uses benzyl alcohol as a raw material to prepare diphenhydramine under the catalysis of dibutyltin oxide and ionic liquid compounds. This type of method has not been reported in other journal articles or foreign patents. Moreover, the ionic liquid compounds used are not commercially available and need to be prepared in-house. Dibutyltin oxide is a tin-based organic compound with high toxicity, posing a high safety risk for scale-up production.
[0019] Route 5: References "Diphenhydramine Citrate Orally Disintegrating Tablets and Their Evaluation" (Chen Li, Master's Thesis)
[0020]
[0021]
[0022] Route Evaluation: Diphenhydramine chloride is prepared by reacting diphenylmethanol with 2-chloroethanol under sulfuric acid catalysis. This intermediate is then reacted with dimethylamine at high temperature in a high-pressure reactor to prepare diphenhydramine. The reaction uses 2-chloroethanol, which is highly toxic, and requires a high-pressure reactor, resulting in harsh reaction conditions and limiting production scale-up.
[0023] To facilitate the efficient preparation of diphenhydramine citrate, it is necessary to develop a superior preparation method to better control the quality of diphenhydramine citrate and provide society with safe, effective, and quality-controlled medicines. Summary of the Invention
[0024] To address the problems existing in the prior art, the purpose of this invention is to provide a method for preparing diphenhydramine citrate, comprising the following steps:
[0025]
[0026] Wherein, X is selected from Br or Cl;
[0027] 1) Compound a, dimethylaminoethanol and an inorganic strong base were dissolved in an organic solvent. After the reaction was completed, the mixture was extracted and the organic phase was concentrated to obtain crude diphenhydramine. The crude diphenhydramine and citric acid were dissolved in an alcohol solvent and water, and crystallized to obtain crude diphenhydramine citric acid.
[0028] 2) The crude diphenhydramine citrate was dissolved in an alcohol solvent and water, and crystallized to obtain purified diphenhydramine citrate.
[0029] According to an embodiment of the present invention, the inorganic strong base in step 1) is selected from sodium hydroxide, potassium hydroxide, and lithium hydroxide.
[0030] According to an embodiment of the present invention, the organic solvent in step 1) is selected from toluene, xylene, tetrahydrofuran, dioxane, and 2-methyltetrahydrofuran.
[0031] According to an embodiment of the present invention, the molar ratio of compound a in step 1) to the dimethylaminoethanol is selected from 1:(1.0 to 3), for example 1:(1.5 to 2.5), such as 1:1.5, 1:2, 1:2.5.
[0032] According to an embodiment of the present invention, the molar ratio of compound a in step 1) to the inorganic strong base is selected from 1:(2 to 10), for example 1:(4 to 8), such as 1:4, 1:5, 1:6.
[0033] According to an embodiment of the present invention, the mass ratio of compound a to the volume ratio of the organic solvent in step 1) is selected from 1g:(1-10)mL, for example 1g:(2-4)mL, such as 1g:2mL, 1g:3mL, 1g:4mL, 1g:5mL, 1g:6mL.
[0034] According to an embodiment of the present invention, the reaction temperature in step 1) is selected from 80-120°C, for example 90-110°C, such as 100-110°C.
[0035] According to an embodiment of the present invention, step 1) further includes cooling the reaction solution to room temperature and filtering it after the reaction is completed and before extraction.
[0036] According to an embodiment of the present invention, the molar ratio of compound a to citric acid in step 1) is selected from 1:(0.9 to 1.2), for example 1:(1 to 1.1), such as 1:1, 1:05, 1:1.
[0037] According to an embodiment of the present invention, the mass ratio of compound a in step 1) to the total volume of alcohol solvent and water is selected from 1g:(1-8)mL, for example 1g:(2-6)mL, such as 1g:2mL, 1g:3mL, 1g:4mL, 1g:5mL, 1g:6mL.
[0038] According to an embodiment of the present invention, the volume ratio of the alcohol solvent and water in step 1) is selected from (2-8):1, for example (3-6):1, such as 4:1, 4.5:1, 5:1.
[0039] According to an embodiment of the present invention, step 1) further includes a step of heating and dissolving before crystallization, wherein the heating temperature is selected from 50-90°C, for example 60-80°C.
[0040] According to an embodiment of the present invention, the crystallization temperature in step 1) is selected from 10-40°C, for example 20-30°C.
[0041] According to an embodiment of the present invention, the alcohol solvent in steps 1) and 2) is selected from at least one of methanol, ethanol or isopropanol.
[0042] According to an embodiment of the present invention, the mass ratio of the crude diphenhydramine citrate to the volume ratio of the alcohol solvent in step 2) is selected from 1g:(1-8)mL, for example 1g:(1-5)mL, such as 1g:1mL, 1g:2mL, 1g:3mL, 1g:4mL, 1g:5mL.
[0043] According to an embodiment of the present invention, the mass ratio of the crude diphenhydramine citrate to the volume of water in step 2) is selected from 1g:(0.1-3)mL, for example 1g:(0.2-2)mL, such as 1g:0.5mL, 1g:1mL, 1g:1.5mL, 1g:2mL.
[0044] According to an embodiment of the present invention, step 2) further includes the steps of heating and dissolving before crystallization and hot filtering, wherein the heating temperature is selected from 50-90°C, for example 60-80°C.
[0045] According to an embodiment of the present invention, the crystallization temperature in step 2) is selected from 10-50°C, for example 20-40°C.
[0046] According to an embodiment of the present invention, the method includes the following steps:
[0047] 1) Synthesis of crude diphenhydramine citrate: Under nitrogen protection, diphenylbromomethane, dimethylaminoethanol, sodium hydroxide and toluene were added to a reaction flask. After the addition was complete, the system was heated and stirred to react. After the reaction was complete, the mixture was cooled and filtered. The mixture was washed with toluene and / or purified water. The toluene layer was distilled under reduced pressure. Ethanol and purified water were added to the concentrate and stirred to dissolve. Citric acid was then added and heated to dissolve the solidified product. After cooling, the solidified product was crystallized to obtain crude diphenhydramine citrate.
[0048] 2) Purification of crude diphenhydramine citrate: Add ethanol and purified water to crude diphenhydramine citrate, heat the system to dissolve it, and then cool it to crystallize and obtain purified diphenhydramine citrate.
[0049] Beneficial effects
[0050] The preparation process adopted in this invention has better safety, is more convenient to operate, and has lower equipment requirements compared with existing processes. It only requires one reaction and one recrystallization to obtain a raw material with high purity and high yield. The production cycle is short, the cost is low, and the overall process yield reaches 70-85%, making it easier to industrialize. Attached Figure Description
[0051] Figure 1 The HPLC chromatogram of Example 1;
[0052] Figure 2 The HPLC chromatogram for Example 2;
[0053] Figure 3 The HPLC chromatogram for Example 3;
[0054] Figure 4 The HPLC chromatogram for Example 4 is shown below.
[0055] Figure 5 This is the hydrogen NMR spectrum of diphenhydramine citrate. Detailed Implementation
[0056] The technical solutions of this disclosure will be further described in detail below with reference to specific embodiments. It should be understood that the following embodiments are merely illustrative and explanatory of this disclosure and should not be construed as limiting the scope of protection of this disclosure. All technologies implemented based on the above content of this disclosure are covered within the scope of protection intended by this disclosure.
[0057] Unless otherwise stated, the raw materials and reagents used in the following examples are commercially available products or can be prepared by known methods.
[0058] The complete process flow diagram of this invention is as follows:
[0059]
[0060] Example 1
[0061] Under nitrogen protection, 30g of diphenylbromomethane, 16.2g of dimethylaminoethanol, 19.4g of sodium hydroxide, and 90ml of toluene were added to a reaction flask. After the addition was complete, the system was heated to 90-110℃ and stirred for 6 hours before the reaction was stopped. The reaction was then cooled to 25℃ and filtered. The filter cake was washed with 30ml of toluene, and the filtrate was washed twice with 60ml of purified water. The aqueous layer was discarded, and the toluene layer was distilled under reduced pressure. After distillation, 120ml of ethanol and 30ml of purified water were added to the concentrate, and the concentrate was stirred to dissolve it. After dissolution, 23.3g of citric acid was added, and the system was stirred and heated to 70℃ until it was clear. The reaction was carried out for 1 hour, and then cooled to 20℃ to crystallize. After the crystals precipitated, they were stirred at this temperature to grow crystals for 1 hour.
[0062] Filter and wash with 30 ml of ethanol to obtain crude diphenhydramine citrate.
[0063] Add 90 ml of ethanol and 30 ml of purified water to crude diphenhydramine citrate. Heat the system to 70°C to dissolve the crystals. After dissolving, hot filter the solution, wash with ethanol, and cool the filtrate to 40°C to crystallize. After crystallization, stir and grow the crystals at this temperature for 1 hour, and then cool the solution to 20°C and stir to crystallize for 1 hour.
[0064] After filtration, washing with 30 ml of ethanol, and drying, 39.8 g of diphenhydramine citrate was obtained as white crystals with a yield of 73.3% and an HPLC purity of 99.934% (acid radical + base).
[0065] Example 2
[0066] Under nitrogen protection, 30g of diphenylbromomethane, 27.1g of dimethylaminoethanol, 24.3g of sodium hydroxide, and 120ml of toluene were added to a reaction flask. After the addition was complete, the system was heated to 90-110℃ and stirred for 7 hours before the reaction was stopped. The reaction was then cooled to 25℃ and filtered. The filter cake was washed with 15ml of toluene, and the filtrate was washed twice with 30ml of purified water. The aqueous layer was discarded, and the toluene layer was distilled under reduced pressure. After distillation, 90ml of ethanol and 20ml of purified water were added to the concentrate, and the concentrate was stirred to dissolve it. After dissolution, 25.7g of citric acid was added, and the system was stirred and heated to 70℃ until it was clear. The reaction was carried out for 1 hour, and then cooled to 20℃ to crystallize. After the crystals precipitated, they were stirred at this temperature to grow crystals for 1 hour.
[0067] Filter and wash with 30 ml of ethanol to obtain crude diphenhydramine citrate.
[0068] Add 90 ml of ethanol and 20 ml of purified water to crude diphenhydramine citrate. Heat the system to 70°C to dissolve the crystals. After dissolving, hot filter the solution, wash with ethanol, and cool the filtrate to 40°C to crystallize. After crystallization, stir and grow the crystals at this temperature for 1 hour, and then cool the solution to 20°C and stir to crystallize for 1 hour.
[0069] After filtration, washing with 30 ml of ethanol, and drying, 41.3 g of diphenhydramine citrate was obtained as white crystals with a yield of 76.0% and an HPLC purity of 99.950% (acid radical + base).
[0070] Example 3
[0071] Under nitrogen protection, 30g of diphenylbromomethane, 21.6g of dimethylaminoethanol, 29.1g of sodium hydroxide, and 60ml of toluene were added to a reaction flask. After the addition was complete, the system was heated to 100-110℃ and stirred for 5 hours before the reaction was stopped. The reaction was then cooled to 25℃ and filtered. The filter cake was washed with 20ml of toluene, and the filtrate was washed twice with 20ml of purified water. The aqueous layer was discarded, and the toluene layer was distilled under reduced pressure. After distillation, 75ml of ethanol and 15ml of purified water were added to the concentrate, and the concentrate was stirred to dissolve it. After dissolution, 24.5g of citric acid was added, and the system was stirred and heated to 70℃ until it was clear. The reaction was carried out for 1 hour, and then cooled to 20℃ to crystallize. After the crystals precipitated, they were stirred at this temperature to grow crystals for 1 hour.
[0072] Filter and wash with 20 ml of ethanol to obtain crude diphenhydramine citrate.
[0073] Add 75 ml of ethanol and 15 ml of purified water to crude diphenhydramine citrate, and heat the system to 70°C to dissolve it. After dissolving, filter the solution hot, wash with ethanol, and cool the filtrate to 40°C to crystallize. After crystallization, stir and grow the crystals at this temperature for 1 hour, and then cool the solution to 20°C and stir to crystallize for 1 hour.
[0074] After filtration, washing with 20 ml of ethanol, and drying, 45.1 g of diphenhydramine citrate was obtained as white crystals with a yield of 83.0% and an HPLC purity of 99.929% (acid radical + base).
[0075] Example 4
[0076] Under nitrogen protection, 30g of diphenylbromomethane, 21.6g of dimethylaminoethanol, 24.3g of sodium hydroxide, and 60ml of toluene were added to a reaction flask. After the addition was complete, the system was heated to 100-110℃ and stirred for 6 hours before the reaction was stopped. The reaction was then cooled to 25℃ and filtered. The filter cake was washed with 15ml of toluene, and the filtrate was washed twice with 15ml of purified water. The aqueous layer was discarded, and the toluene layer was distilled under reduced pressure. After distillation, 75ml of ethanol and 15ml of purified water were added to the concentrate, and the concentrate was stirred to dissolve it. After dissolution, 23.3g of citric acid was added, and the system was stirred and heated to 70℃ until it was clear. The reaction was carried out for 1 hour, and then cooled to 20℃ to crystallize. After the crystals precipitated, they were stirred at this temperature to grow crystals for 1 hour.
[0077] Filter and wash with 15 ml of ethanol to obtain crude diphenhydramine citrate.
[0078] Add 60 ml of ethanol and 15 ml of purified water to crude diphenhydramine citrate. Heat the system to 70°C to dissolve the crystals. After dissolving, hot filter the solution, wash with 15 ml of ethanol, cool the filtrate to 40°C to crystallize, and stir at this temperature for 1 hour to allow crystals to grow. Then cool the solution to 20°C and stir to allow crystals to crystallize for another hour.
[0079] After filtration, washing with ethanol, and drying, 45.6 g of diphenhydramine citrate was obtained as white crystals with a yield of 83.9% and an HPLC purity of 99.961% (acid radical + base).
[0080] 1 H-NMR(600MHz,DMSO)δ11.016(s,4H,OH),7.395-7.407(t,4H,CH),7.337-7.362(t,4H,CH),7.265(t,2H, CH),5.535(s,1H,CH),3.620(t,2H,CH2),3.184(t,2H,CH2),2.679(s,6H,CH3),2.505-2.578(s,4H,CH2).
[0081] ES-MS M / Z = 255.4(M+).
[0082] Comparative Example
[0083] Preparation of diphenhydramine citrate
[0084] Under nitrogen protection, 30g of diphenylbromomethane, 16.2g of dimethylaminoethanol, 25.8g of sodium carbonate, and 90ml of DMSO were added to a reaction flask. After the addition was complete, the system was heated to 150℃ and stirred for 8 hours before the reaction was stopped. The reaction was then cooled to 20-30℃ and filtered. The filter cake was washed with 50ml of ethyl acetate. The filtrate was concentrated under reduced pressure at 120℃ using an oil pump to obtain an oily substance. 150ml of ethyl acetate was added to dissolve the oil, and the mixture was washed twice with 50ml of purified water. The ethyl acetate layer was distilled under reduced pressure. After distillation, 120ml of ethanol and 30ml of purified water were added to the concentrate, and the concentrate was stirred to dissolve it. After dissolution, 23.3g of citric acid was added, and the mixture was stirred and heated to 70℃ until the system was clear. The reaction was carried out for 1 hour, and then cooled to 20℃ to crystallize. After crystals precipitated, the crystals were stirred at this temperature for 1 hour to allow them to crystallize.
[0085] Filter, wash with 30 ml of ethanol to obtain crude diphenhydramine citrate;
[0086] Add 90 ml of ethanol and 30 ml of purified water to crude diphenhydramine citrate. Heat the system to 70°C to dissolve the crystals. After dissolving, hot filter the solution, wash with ethanol, and cool the filtrate to 40°C to crystallize. After crystallization, stir and grow the crystals at this temperature for 1 hour, and then cool the solution to 20°C and stir to crystallize for 1 hour.
[0087] After filtration, washing with 30 ml of ethanol, and drying, 24.8 g of diphenhydramine citrate was obtained as yellowish-white crystals with a yield of 45.7% and an HPLC purity of 98.947% (acid radical + base).
[0088] The above description provides an exemplary account of the implementation methods of the technical solution disclosed herein. It should be understood that the scope of protection of this disclosure is not limited to the above-described embodiments. Any modifications, equivalent substitutions, or improvements made by those skilled in the art within the spirit and principles of this disclosure should be included within the scope of protection of the claims of this application.
Claims
1. A method for preparing diphenhydramine citrate, comprising the following steps: in, X is selected from Br or Cl; 1) Compound a, dimethylaminoethanol and an inorganic strong base were dissolved in an organic solvent. After the reaction was completed, the mixture was extracted and the organic phase was concentrated to obtain crude diphenhydramine. The crude diphenhydramine and citric acid were dissolved in an alcohol solvent and water, and crystallized to obtain crude diphenhydramine citric acid. 2) The crude diphenhydramine citrate was dissolved in an alcohol solvent and water, and crystallized to obtain purified diphenhydramine citrate.
2. The method according to claim 1, characterized in that, The inorganic strong base mentioned in step 1) is selected from sodium hydroxide, potassium hydroxide, and lithium hydroxide; Preferably, the organic solvent in step 1) is selected from toluene, xylene, tetrahydrofuran, dioxane, and 2-methyltetrahydrofuran.
3. The method according to claim 1 or 2, characterized in that, In step 1), the molar ratio of compound a to dimethylaminoethanol is selected from 1:(1.0-3), for example 1:(1.5-2.5); Preferably, the molar ratio of compound a in step 1) to the inorganic strong base is selected from 1:(2 to 10), for example 1:(4 to 8).
4. The method according to any one of claims 1-3, characterized in that, Step 1) The mass ratio of compound a to the volume ratio of the organic solvent is selected from 1 g:(1-10) mL, for example 1 g:(2-4) mL; Preferably, the reaction temperature in step 1) is selected from 80-120℃, for example 90-110℃, such as 100-110℃; Preferably, step 1) further includes cooling the reaction solution to room temperature and filtering it after the reaction is completed and before extraction.
5. The method according to any one of claims 1-4, characterized in that, The molar ratio of compound a to citric acid in step 1) is selected from 1:(0.9 to 1.2), for example 1:(1 to 1.1); Preferably, the mass ratio of compound a in step 1) to the total volume ratio of alcohol solvent and water is selected from 1g:(1-8)mL, for example 1g:(2-6)mL; Preferably, the volume ratio of the alcohol solvent and water in step 1) is selected from (2-8):1, for example from (3-6):
1.
6. The method according to any one of claims 1-5, characterized in that, Step 1) also includes a step of heating and dissolving before crystallization, wherein the heating temperature is selected from 50-90°C, for example 60-80°C; Preferably, the crystallization temperature in step 1) is selected from 10-40°C, for example 20-30°C.
7. The method according to any one of claims 1-6, characterized in that, The alcohol solvents mentioned in steps 1) and 2) are selected from at least one of methanol, ethanol or isopropanol.
8. The method according to any one of claims 1-7, characterized in that, Step 2) The mass ratio of the crude diphenhydramine citrate to the volume ratio of the alcohol solvent is selected from 1 g: (1-8) mL, for example 1 g: (1-5) mL; Preferably, the mass ratio of crude diphenhydramine citrate to the volume of water in step 2) is selected from 1g:(0.1-3)mL, for example 1g:(0.2-2)mL.
9. The method according to any one of claims 1-8, characterized in that, Step 2) also includes the steps of heating and dissolving before crystallization and hot filtering, wherein the heating temperature is selected from 50-90°C, for example 60-80°C. Preferably, the crystallization temperature in step 2) is selected from 10-50°C, for example 20-40°C.
10. The method according to any one of claims 1-9, characterized in that, The method includes the following steps: 1) Synthesis of crude diphenhydramine citrate: Under nitrogen protection, diphenylbromomethane, dimethylaminoethanol, sodium hydroxide and toluene were added to a reaction flask. After the addition was complete, the system was heated and stirred to react. After the reaction was complete, the mixture was cooled and filtered. The mixture was washed with toluene and / or purified water. The toluene layer was distilled under reduced pressure. Ethanol and purified water were added to the concentrate and stirred to dissolve. Citric acid was then added and heated to dissolve the solidified product. After cooling, the solidified product was crystallized to obtain crude diphenhydramine citrate. 2) Purification of crude diphenhydramine citrate: Add ethanol and purified water to crude diphenhydramine citrate, heat the system to dissolve it, and then cool it to crystallize and obtain purified diphenhydramine citrate.
Citation Information
Patent Citations
Preparation method of diphenhydramine
CN103265439B
The preparation method of diphenhydramine
CN104892435B
